Why did the Indivior share price rise 14% today?

The Indivior share price rocketed 14% higher today on the back of a positive full-year report and a potential dual-listing.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

The Indivior (LSE:INDV) share price was up 14% today on the back of a positive full-year report. In the 2021 fiscal year, Invidior, a pharmaceutical company specialising in opioid addiction treatments, grew its revenues by 22%. The return of routine visits to clinics and hospitals has undoubtedly helped Indivior. But the company has also been expanding the market share of its SUBLOCADE injectable treatment for opioid addiction. Sales of PERSERIS, a treatment for schizophrenia, are up 21% in 2021, representing good progress in treatment portfolio diversification.

Indivior reported a net income of $205m in 2022 compared to a loss of $148m in 2021. But, for all the fiscal good news, what seems to have garnered the most attention is the board mulling over the possibility of a dual-listing for Indivior shares.

Inflation Is Coming

Inflation is out of control, and people are running scared. But right now there’s one thing we believe Investors should avoid doing at all costs… and that’s doing nothing. That’s why we’ve put together a special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation… and better still, we’re giving it away completely FREE today!

Click here to claim your copy now!

Dual-listing Indivior shares

Indivior derives about 80% of its revenue in the US. The large US revenue component has got Indivior’s board thinking about an additional US listing for the company’s shares. Today, the board has indicated they are actively assessing the possibility of a dual-listing but would consult Indivior’s shareholders before moving forward.

The most common way for a non-US entity to list on American exchanges is with American Depositary Receipts (ADRs). To create an Indivior ADR, Indivior stock is bought on the London Stock Exchange and given to a depositary bank in the US. The depositary bank issues ADRs, which represent one or more or a fraction of the Indivior shares it holds. Brokers or dealers then take the ADRs to the US stock markets to be bought and sold.

Would dual-listing be good for the Invidior share price

Dual-listing can improve a company’s profile and visibility. Raising capital in two capital markets should be easier. A dual-listing across the US and UK would increase the time Invidior shares trade on a given day and increase liquidity. These factors sound positive for the Invidior share price.

On the other hand, dual-listings incur an expense to set up. There are also ongoing expenses from dealing with different regulatory and accounting requirements (the US uses GAAP and the UK, IFRS) and from communicating with two investor bases. Dual-listed companies tend to be quite large, perhaps a reflection of the complexities involved. Indivior, at a market cap of £1.6bn, is small compared to the other dual-listed companies.

Dual-listing might be positive for the Invidior share price. But then again, it might not. I would point to some old but still relevant research from Mckinsey that suggests that, on average, dual-listings do not create value in any measurable way.

Why did the Indivior share price rise today?

Given the buzz around the dual-listing, I would suggest this helped lift the share price. However, the solid financial performance Indivior produced in 2021 is also a massive factor. Of the two reasons, I think the second, if it continues, will drive the share price in the future.

Indivior entered agreements in 2020 to resolve criminal charges and civil complaints related to one of its opioid addiction treatments in the US. There are penalties for failing to meet them. In addition, there are hundreds of preliminary stage civil lawsuits brought against the company as part of the opioid class action litigation. Legal risks remain high for Indivior.

FREE REPORT: Why this £5 stock could be set to surge

Are you on the lookout for UK growth stocks?

If so, get this FREE no-strings report now.

While it’s available: you'll discover what we think is a top growth stock for the decade ahead.

And the performance of this company really is stunning.

In 2019, it returned £150million to shareholders through buybacks and dividends.

We believe its financial position is about as solid as anything we’ve seen.

  • Since 2016, annual revenues increased 31%
  • In March 2020, one of its senior directors LOADED UP on 25,000 shares – a position worth £90,259
  • Operating cash flow is up 47%. (Even its operating margins are rising every year!)

Quite simply, we believe it’s a fantastic Foolish growth pick.

What’s more, it deserves your attention today.

So please don’t wait another moment.

Get the full details on this £5 stock now – while your report is free.

James J. McCombie owns shares in Indivior. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Should you invest the value of your investment may rise or fall and your Capital is at Risk. Before investing your individual circumstances should be considered, so you should consider taking independent financial advice.

More on Investing Articles

Preparing a budget during a pandemic
Investing Articles

2 high-potential FTSE 250 stocks to buy and hold for 5 years!

The FTSE 250 is a good place to search for the next big British stocks. So, here are two companies…

Read more »

Black father holding daughter in a field of cows
Investing Articles

Could my Stocks and Shares ISA generate £30,000 a year?

Over 2m UK citizens make some use of a Stocks and Shares ISA every year. Our writer considers if it’s…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

4 dividend stocks that can help me fight inflation!

I'm looking at dividend stocks to help my portfolio grow and overcome the impact of high inflation. Here are the…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

2 bargain UK shares trading at less than book value

Book value is a great way to value a stock. These UK shares are trading at a price-to-book ratio of…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

A FTSE AIM stock I’d add to my Stocks & Shares ISA in July

Henry Adefope highlights a FTSE AIM stock he believes could generate significant upside for his portfolio if he buys this…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

I’m following Warren Buffett and buying cheap dividend shares to build my wealth

I think this cheap dividend stock exhibits similar qualities to the companies Warren Buffett has in his investment portfolio.

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

2 cheap FTSE 100 shares I’m buying during the dip!

Andrew Woods explains that low P/E ratios and profitable businesses attract him to these two FTSE 100 shares.

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Down 45% in a year, is now the time to buy Scottish Mortgage shares?

Jon Smith explains why Scottish Mortgage shares appear to him to be good value given their post-pandemic fall.

Read more »